Other OTC - Delayed Quote USD

Item 9 Labs Corp. (INLB)

0.0001 0.0000 (0.00%)
At close: April 19 at 3:13 PM EDT
Loading Chart for INLB
DELL
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.1000
  • Volume 30,000
  • Avg. Volume 17,472,675
  • Market Cap (intraday) 10,236
  • Beta (5Y Monthly) 0.69
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3300
  • Earnings Date May 20, 2024 - May 24, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

www.item9labscorp.com

97

Full Time Employees

September 30

Fiscal Year Ends

Recent News: INLB

Performance Overview: INLB

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INLB
94.74%
S&P 500
4.14%

1-Year Return

INLB
99.90%
S&P 500
19.55%

3-Year Return

INLB
100.00%
S&P 500
18.68%

5-Year Return

INLB
100.00%
S&P 500
70.99%

Compare To: INLB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INLB

Valuation Measures

As of 4/18/2024
  • Market Cap

    10.24k

  • Enterprise Value

    34.12M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    0.00

  • Enterprise Value/Revenue

    1.73

  • Enterprise Value/EBITDA

    -1.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -157.61%

  • Return on Assets (ttm)

    -5.40%

  • Return on Equity (ttm)

    -47.35%

  • Revenue (ttm)

    19.69M

  • Net Income Avi to Common (ttm)

    -31.03M

  • Diluted EPS (ttm)

    -0.3300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    183.43k

  • Total Debt/Equity (mrq)

    65.14%

  • Levered Free Cash Flow (ttm)

    9.99M

Research Analysis: INLB

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

People Also Watch